Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-O-C4-COOH is a synthetic conjugate compound, serving as an E3 ligase ligand-linker, which combines a cereblon ligand derived from Thalidomide and a linker utilized in PROTAC technology.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 35 days | $ 784.00 |
Description | Thalidomide-O-C4-COOH is a synthetic conjugate compound, serving as an E3 ligase ligand-linker, which combines a cereblon ligand derived from Thalidomide and a linker utilized in PROTAC technology. |
In vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
Synonyms | Thalidomide-O-C4-COOH |
Molecular Weight | 374.3447 |
Formula | C18H18N2O7 |
CAS No. | 2169266-67-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-O-C4-COOH 2169266-67-3 ThalidomideOC4COOH Thalidomide O C4 COOH Thalidomide-O-C-4-COOH inhibitor inhibit